Some Countries Ease Lockdowns, But Others Battle New COVID-19 Surges 23/02/2021 Raisa Santos & Kerry Cullinan The United Kingdom, Switzerland, Israel and Turkey are cautiously reopening businesses and relaxing limits on gatherings and travel as COVID-19 cases declined both globally and within these countries. However, parts of France, the Czech Republic, and Sweden are preparing for harder lockdown measures as their cases surge in contrast to worldwide trends. As of 23 […] Continue reading -> Global Citizen Launches ‘Recover Better Together’ Campaign – Guinea Launches Ebola Vaccinations – Nigeria & Zambia Studies Show High SARS-CoV2 Infections 23/02/2021 Kerry Cullinan Vaccinating all of Africa’s health workers would need half a percent of all the doses that the G-7 countries have purchased, according to Global Citizen CEO Hugh Evans. On Tuesday, Global Citizen launched a five-point ‘Recover Better Together’ plan for the world, aimed at getting millions of citizens behind ending COVID-19 for all, ending the […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Low- & Middle-Income Countries in Africa and Middle East Begin Vaccine Rollout 16/02/2021 Madeleine Hoecklin & Kerry Cullinan As low- and middle-income countries begin receiving their first batches of vaccines and commence their vaccination campaigns, at least 40 countries across Africa are seeing a second wave and record case numbers are being reported in the southern African region, where the B.1.351 variant is spreading. Rwanda has become the first country in East Africa […] Continue reading -> South African Health Workers To Get J&J Vaccine As Part of Implementation Trial – AstraZeneca Vaccines Will Be Offered To African Union 16/02/2021 Kerry Cullinan Cape Town – The first South African health workers will be vaccinated against SARS-CoV2 on Wednesday with the Johnson & Johnson vaccine, instead of the AstraZeneca vaccine, which was recently shown to be unable to stop mild or moderate infection against the B.1351 (501Y.V2) variant dominant in South Africa. In a hastily assembled Plan B, […] Continue reading -> AstraZeneca COVID Vaccine Manufacturers Get WHO OK, Opening Door To COVAX Distribution – WHO Deflects Experts’ Criticism About China Trip To Explore Vaccine Origins 15/02/2021 Kerry Cullinan The AstraZeneca/Oxford COVID-19 vaccines being produced by the Serum Institute of India and SK Bio in South Korea were listed for emergency use by the World Health Organization (WHO) on Monday. Emergency use listing (EUL), which involves experts assessing their safety, efficacy and quality, is a prerequisite for vaccines before they can be distributed by […] Continue reading -> None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Citizen Launches ‘Recover Better Together’ Campaign – Guinea Launches Ebola Vaccinations – Nigeria & Zambia Studies Show High SARS-CoV2 Infections 23/02/2021 Kerry Cullinan Vaccinating all of Africa’s health workers would need half a percent of all the doses that the G-7 countries have purchased, according to Global Citizen CEO Hugh Evans. On Tuesday, Global Citizen launched a five-point ‘Recover Better Together’ plan for the world, aimed at getting millions of citizens behind ending COVID-19 for all, ending the […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Low- & Middle-Income Countries in Africa and Middle East Begin Vaccine Rollout 16/02/2021 Madeleine Hoecklin & Kerry Cullinan As low- and middle-income countries begin receiving their first batches of vaccines and commence their vaccination campaigns, at least 40 countries across Africa are seeing a second wave and record case numbers are being reported in the southern African region, where the B.1.351 variant is spreading. Rwanda has become the first country in East Africa […] Continue reading -> South African Health Workers To Get J&J Vaccine As Part of Implementation Trial – AstraZeneca Vaccines Will Be Offered To African Union 16/02/2021 Kerry Cullinan Cape Town – The first South African health workers will be vaccinated against SARS-CoV2 on Wednesday with the Johnson & Johnson vaccine, instead of the AstraZeneca vaccine, which was recently shown to be unable to stop mild or moderate infection against the B.1351 (501Y.V2) variant dominant in South Africa. In a hastily assembled Plan B, […] Continue reading -> AstraZeneca COVID Vaccine Manufacturers Get WHO OK, Opening Door To COVAX Distribution – WHO Deflects Experts’ Criticism About China Trip To Explore Vaccine Origins 15/02/2021 Kerry Cullinan The AstraZeneca/Oxford COVID-19 vaccines being produced by the Serum Institute of India and SK Bio in South Korea were listed for emergency use by the World Health Organization (WHO) on Monday. Emergency use listing (EUL), which involves experts assessing their safety, efficacy and quality, is a prerequisite for vaccines before they can be distributed by […] Continue reading -> None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Low- & Middle-Income Countries in Africa and Middle East Begin Vaccine Rollout 16/02/2021 Madeleine Hoecklin & Kerry Cullinan As low- and middle-income countries begin receiving their first batches of vaccines and commence their vaccination campaigns, at least 40 countries across Africa are seeing a second wave and record case numbers are being reported in the southern African region, where the B.1.351 variant is spreading. Rwanda has become the first country in East Africa […] Continue reading -> South African Health Workers To Get J&J Vaccine As Part of Implementation Trial – AstraZeneca Vaccines Will Be Offered To African Union 16/02/2021 Kerry Cullinan Cape Town – The first South African health workers will be vaccinated against SARS-CoV2 on Wednesday with the Johnson & Johnson vaccine, instead of the AstraZeneca vaccine, which was recently shown to be unable to stop mild or moderate infection against the B.1351 (501Y.V2) variant dominant in South Africa. In a hastily assembled Plan B, […] Continue reading -> AstraZeneca COVID Vaccine Manufacturers Get WHO OK, Opening Door To COVAX Distribution – WHO Deflects Experts’ Criticism About China Trip To Explore Vaccine Origins 15/02/2021 Kerry Cullinan The AstraZeneca/Oxford COVID-19 vaccines being produced by the Serum Institute of India and SK Bio in South Korea were listed for emergency use by the World Health Organization (WHO) on Monday. Emergency use listing (EUL), which involves experts assessing their safety, efficacy and quality, is a prerequisite for vaccines before they can be distributed by […] Continue reading -> None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Low- & Middle-Income Countries in Africa and Middle East Begin Vaccine Rollout 16/02/2021 Madeleine Hoecklin & Kerry Cullinan As low- and middle-income countries begin receiving their first batches of vaccines and commence their vaccination campaigns, at least 40 countries across Africa are seeing a second wave and record case numbers are being reported in the southern African region, where the B.1.351 variant is spreading. Rwanda has become the first country in East Africa […] Continue reading -> South African Health Workers To Get J&J Vaccine As Part of Implementation Trial – AstraZeneca Vaccines Will Be Offered To African Union 16/02/2021 Kerry Cullinan Cape Town – The first South African health workers will be vaccinated against SARS-CoV2 on Wednesday with the Johnson & Johnson vaccine, instead of the AstraZeneca vaccine, which was recently shown to be unable to stop mild or moderate infection against the B.1351 (501Y.V2) variant dominant in South Africa. In a hastily assembled Plan B, […] Continue reading -> AstraZeneca COVID Vaccine Manufacturers Get WHO OK, Opening Door To COVAX Distribution – WHO Deflects Experts’ Criticism About China Trip To Explore Vaccine Origins 15/02/2021 Kerry Cullinan The AstraZeneca/Oxford COVID-19 vaccines being produced by the Serum Institute of India and SK Bio in South Korea were listed for emergency use by the World Health Organization (WHO) on Monday. Emergency use listing (EUL), which involves experts assessing their safety, efficacy and quality, is a prerequisite for vaccines before they can be distributed by […] Continue reading -> None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Low- & Middle-Income Countries in Africa and Middle East Begin Vaccine Rollout 16/02/2021 Madeleine Hoecklin & Kerry Cullinan As low- and middle-income countries begin receiving their first batches of vaccines and commence their vaccination campaigns, at least 40 countries across Africa are seeing a second wave and record case numbers are being reported in the southern African region, where the B.1.351 variant is spreading. Rwanda has become the first country in East Africa […] Continue reading -> South African Health Workers To Get J&J Vaccine As Part of Implementation Trial – AstraZeneca Vaccines Will Be Offered To African Union 16/02/2021 Kerry Cullinan Cape Town – The first South African health workers will be vaccinated against SARS-CoV2 on Wednesday with the Johnson & Johnson vaccine, instead of the AstraZeneca vaccine, which was recently shown to be unable to stop mild or moderate infection against the B.1351 (501Y.V2) variant dominant in South Africa. In a hastily assembled Plan B, […] Continue reading -> AstraZeneca COVID Vaccine Manufacturers Get WHO OK, Opening Door To COVAX Distribution – WHO Deflects Experts’ Criticism About China Trip To Explore Vaccine Origins 15/02/2021 Kerry Cullinan The AstraZeneca/Oxford COVID-19 vaccines being produced by the Serum Institute of India and SK Bio in South Korea were listed for emergency use by the World Health Organization (WHO) on Monday. Emergency use listing (EUL), which involves experts assessing their safety, efficacy and quality, is a prerequisite for vaccines before they can be distributed by […] Continue reading -> None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South African Health Workers To Get J&J Vaccine As Part of Implementation Trial – AstraZeneca Vaccines Will Be Offered To African Union 16/02/2021 Kerry Cullinan Cape Town – The first South African health workers will be vaccinated against SARS-CoV2 on Wednesday with the Johnson & Johnson vaccine, instead of the AstraZeneca vaccine, which was recently shown to be unable to stop mild or moderate infection against the B.1351 (501Y.V2) variant dominant in South Africa. In a hastily assembled Plan B, […] Continue reading -> AstraZeneca COVID Vaccine Manufacturers Get WHO OK, Opening Door To COVAX Distribution – WHO Deflects Experts’ Criticism About China Trip To Explore Vaccine Origins 15/02/2021 Kerry Cullinan The AstraZeneca/Oxford COVID-19 vaccines being produced by the Serum Institute of India and SK Bio in South Korea were listed for emergency use by the World Health Organization (WHO) on Monday. Emergency use listing (EUL), which involves experts assessing their safety, efficacy and quality, is a prerequisite for vaccines before they can be distributed by […] Continue reading -> None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca COVID Vaccine Manufacturers Get WHO OK, Opening Door To COVAX Distribution – WHO Deflects Experts’ Criticism About China Trip To Explore Vaccine Origins 15/02/2021 Kerry Cullinan The AstraZeneca/Oxford COVID-19 vaccines being produced by the Serum Institute of India and SK Bio in South Korea were listed for emergency use by the World Health Organization (WHO) on Monday. Emergency use listing (EUL), which involves experts assessing their safety, efficacy and quality, is a prerequisite for vaccines before they can be distributed by […] Continue reading -> None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
None of SARS-CoV2 Origin Hypotheses Have Been Discarded, Says WHO 12/02/2021 Kerry Cullinan None of the hypotheses about the origins of the SARS-CoV2 virus have been discarded and the World Health Organization (WHO) origins mission might be expanded to include other experts to take forward new areas of research, WHO Director General Dr Tedros Adhanom Ghebreyesus told the body’s bi-weekly media briefing on Friday. “I wish to confirm […] Continue reading -> WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Experts Unable to Find ‘Missing Link’ in SARS-CoV2 Virus Transmission in China 09/02/2021 Kerry Cullinan & Elaine Ruth Fletcher The most likely way that the SARS-CoV2 virus spread in Wuhan was from an animal intermediary that transmitted the virus from bats to humans, while the least likely was that it resulted from a laboratory “incident”, according to the World Health Organization (WHO) team on the origin of the virus, which completed a month-long investigation […] Continue reading -> WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Remains Positive About AstraZeneca Despite South Africa Setback; GAVI Calls For Pharma To Rapidly Adapt Products To Variants 08/02/2021 Kerry Cullinan The World Health Organization (WHO)’s expert group on immunisations remains confident in the Oxford/AstraZeneca vaccine’s efficacy against severe SARS-CoV2 disease – despite the enormous worldwide concerns triggered by a small South African study that showed it had little effect in stemming mild disease from the B.1.351 variant first identified in that country. “It is very […] Continue reading -> Posts navigation Older postsNewer posts